BGP Healthcare
India 36 employees Updated 9 July 2026
BGP Healthcare is an API manufacturer based in India. It holds 2 active US drug master files. Its GMP standing is certified by CDSCO (India) and US FDA. Its most recent recorded inspection, by US FDA, closed on 25 January 2024 as VAI.
4
registered plants
1 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
2 of 2 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 25 January 2024 VAI US FDA
- 25 August 2016 NAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| ankleshwar ankleshwar 393 002bharuch, India | Not on file |
| Ankleshwar, India | Not on file |
| Ankleshwar, India | 3008280145 |
| ankleshwar 393 002bharuch, India | Not on file |
What they file, and where
| Molecule | Regulators | Docs |
| Nicotine | US FDA | 2 |
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| CDSCO (India) | None | 3 |
| US FDA | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. BGP Healthcare comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 25 January 2024.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates